IBogaine Thailand

21/07/2026

A recent guest shared their personal experience with our programme and what the journey meant to them. Their story reminded us why we have continued this work for the past 12 years.

We’re grateful for their trust and permission to share their journey.

Individual experiences vary, and medical screening is required before treatment.

Read their story via the link in the comments.

18/07/2026

Post 7 of 7: Ask a better question
“Can ibogaine cure ADHD?” is too broad and promises an answer the evidence cannot currently provide.

More useful questions include:
• Is this person experiencing ADHD, trauma, or both?
• How much attention is being consumed by hypervigilance?
• Are shame, poor sleep, chronic stress or emotional avoidance intensifying the symptoms?
• What support is needed before treatment?
• What structure will help afterwards?
• How will changes in attention, mood and motivation be monitored?

The client in this series had used medication, therapy, education, breathwork, lifestyle changes and ibogaine. His improvement emerged from several pieces coming together.

For some people, attention problems may exist alongside a deeper difficulty feeling safe, emotionally regulated or connected to motivation.

Our role is to listen carefully, screen thoroughly and support each person before, during and after treatment. The goal reaches beyond better concentration. It is helping a person build enough safety and structure to participate fully in their own life.

17/07/2026

Post 6 of 7: Why safety comes first

Ibogaine carries serious medical risks, particularly involving the heart’s electrical activity.
It should never be combined casually with stimulants, antidepressants, sleep medication or other psychiatric medicines.
For clients with ADHD, our screening process considers:
• Medical and medication history
• ECG results
• Blood work and electrolytes
• Liver function
• Cardiac risk
• Psychological stability
• Preparation and post-treatment support

We do not publish dosing instructions. Treatment decisions depend on individual medical factors and should never be copied from a social-media post.

The client discussed in this series received a measured, carefully observed treatment rather than a standardised approach.
Ibogaine is not an approved ADHD treatment.

We do not claim that it cures ADHD, replaces medication or produces the same outcome for every person.

Anyone considering changes to prescribed medication should speak with their doctor or prescribing clinician. A powerful experience never removes the need for rigorous screening and medical safety.

17/07/2026

Post 5 of 7: What might explain the change?

We do not know precisely why this client experienced such a significant shift.
Several possibilities deserve careful exploration:Reduced hypervigilance.

When less attention is consumed by perceived threats, more may become available for work, relationships and everyday life.

Emotional processing
Ibogaine can produce a prolonged reflective state in which people report revisiting memories, relationships and unresolved emotional experiences.

Changes in motivation and reward
Ibogaine and noribogaine interact with several neurotransmitter systems. Research has not established ibogaine as an ADHD treatment or proven that it “resets” the reward system.

The integration period
After an intense psychological experience, some people may feel more open to changing routines, beliefs and emotional responses. What happens during that period can shape the longer-term outcome.

These remain possible explanations, not confirmed conclusions.
The most grounded interpretation is that addressing trauma and emotional dysregulation may indirectly change some symptoms that resemble or intensify ADHD.

Curiosity opens the research question. Evidence must provide the answer.

16/07/2026

Post 4 of 7: What changed for this client?

Following treatment, this client reported feeling calmer, clearer and more emotionally free.Triggers that once felt threatening became less powerful. Everyday irritations occupied less mental space. He described greater optimism, gratitude and emotional resilience.

He also reported that he had not returned to stimulant medication at the time of follow-up. That was his personal decision and individual experience. We do not advise anyone to stop prescribed medication without support from their doctor or prescribing clinician.

The client described breathwork as helping him regulate his nervous system. He felt that ibogaine changed how he experienced motivation and reward.That description was meaningful to him, but it remains a personal account rather than a proven neurological mechanism.

His improvement also followed years of preparation and self-work. A single intervention cannot be separated cleanly from everything that came before and after it.

This experience made us curious. It did not give us permission to claim a cure.Responsible curiosity means paying attention to meaningful outcomes while remaining honest about what they can prove.

16/07/2026

Post 3 of 7: One client’s experience

A previous client came to us after years of severe inattentive ADHD symptoms.A psychiatrist had diagnosed him and prescribed stimulant medication. He said the medication helped enormously. His mind became quieter, he could think clearly and he felt more emotionally regulated.

When its effects wore off, many of his symptoms returned.

His history also included emotional neglect, criticism, limited affection and little sense of safety during childhood. As an adult, he experienced anxiety, fear of rejection, social discomfort, emotional shutdown and self-sabotage in relationships.

Before coming to IBogaine Thailand, he had already invested considerable effort in understanding himself through therapy, trauma education, breathwork, nutrition, sleep and nervous-system regulation.That context matters.

Ibogaine formed one part of a much larger process. His experience cannot tell us what will happen for another person, and it does not prove that ibogaine treats ADHD.

It does show why we should listen to the person’s entire life story instead of examining attention symptoms in isolation.

A diagnosis can explain part of someone’s experience without explaining all of it.

15/07/2026

Post 2 of 7: ADHD and trauma can look remarkably similar

Poor concentration. Restlessness. Emotional reactivity. Difficulty starting or completing tasks. Forgetfulness. Avoidance.

These experiences can appear in ADHD.

They can also appear in people living with unresolved trauma.

The visible symptoms may look similar, while the processes underneath them differ.

A person affected by trauma may struggle to focus because their brain is continually scanning for danger:

“Am I safe?”

“Will I be rejected?”

“What might go wrong?”

“What did that person mean?”

That constant inner surveillance consumes mental energy. The brain becomes highly skilled at detecting possible threats and less able to settle into calm attention.

This does not mean trauma causes every case of ADHD. Research shows that ADHD and PTSD can co-occur, and people experiencing both may face greater clinical difficulties.

A careful assessment should leave room for the full story.

Sometimes the useful question is not “Why can’t I focus?” It is “What keeps pulling my attention away?”

15/07/2026

ADHD, Trauma and Ibogaine: A More Complex Conversation

Post 1 of 7: When ADHD may be carrying something else

ADHD is usually understood through attention, impulsivity, motivation and executive function.

For many people, that diagnosis accurately describes a genuine neurodevelopmental condition.

Yet some adults arrive at Ibogaine Thailand with a more complicated story.

Alongside attention problems, they may carry childhood trauma, emotional neglect, chronic anxiety, shame, relationship difficulties and a nervous system that rarely feels safe.

This raises an important question:

How much of what they experience comes from ADHD, and how much may be connected to trauma or chronic nervous-system dysregulation?

ADHD and trauma can also exist together. Understanding one should never erase the other.

Over the next seven posts, we’ll explore this overlap, share one client’s experience and explain why screening, preparation and integration matter.

11/07/2026

Well, this is a big one. 🎉

Today marks 12 years of operating Ibogaine Thailand.

Twelve years of growth, hard lessons, meaningful work, and quite a few stories along the way.

Thank you to everyone who has been part of the journey. 🙏

19/03/2026

This podcast episode with Jonathan Dickinson explores ibogaine’s growing role in treatment for traumatic brain injury, addiction, and neurological conditions, along with the importance of screening, preparation, and aftercare. Strong conversation on where this field is heading and why safety matters so much.

Listen here:

Paul F. Austin and Jonathan Dickinson discuss ibogaine's potential for treating trauma and TBI, and the challenge of scaling treatment safely.